Mandate

Vinge advises the sellers of InnovDr in connection with the divestment to Doktor.se

March 15, 2022 M&A

InnovDr is a digital provider of health and medical services. The business, which started in 2016, consists of Kollarna.se and the subareas urinkollen.se, aknekollen.se, borreliakollen.se, menskollen.se, ögonkollen.se and herpeskollen.se.

The owners of InnovDr divest the company to Doktor.se, which is one of the leading companies in digital care in Sweden.

Vinge’s team consisted of Wibeke Sorling, Jenny Sandlund, Hanna Jansson and Amanda Stoltz.

Related

Vinge advises Adelis Equity Partners on the establishment of a continuation fund

Vinge has advised Adelis Equity Partners on the establishment of a continuation fund to Adelis Equity Partners Fund II. The continuation fund is a so-called dual-asset vehicle which will invest in Presto and HVD Group (Hantverksdata) – both current portfolio companies of Adelis Equity Partners Fund II. The continuation fund, in which HarbourVest Partners will be the largest investor, will have EUR 430m in commitments and will invest alongside Adelis Equity Partners Fund III and the Adelis team.
February 21, 2024

Vinge advises Axcel and XPartners in connection with the acquisition of Wavecon

Vinge has advised Axcel VII (“Axcel”) and XPartners Samhällsbyggnad (”XPartners”) in connection with the acquisition of Wavecon AB (”Wavecon”).
February 14, 2024

Vinge advises Axcel and XPartners in connection with the acquisition of Projektstaben

Vinge has advised Axcel VII (“Axcel”) and XPartners Samhällsbyggnad (”XPartners”) in connection with the acquisition of Projektstaben i Sverige AB (”Projektstaben”).
February 14, 2024